New Releases from NCBI BookshelfPembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma.Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma.
Post Content
What Is the Reimbursement Recommendation for Trabectedin?
Canada’s Drug Agency (CDA-AMC) recommends that Nubeqa be reimbursed by public drug plans for use in combination with androgen deprivation
Global crises, such as the COVID-19 pandemic, increase the risk of perinatal depression and anxiety. A recent systematic review of
Recent reports based on the US Food and Drug Administration’s voluntary Adverse Events Reporting System raised questions about the safety
Early relationships are foundational for lifelong health, learning, and well-being. Mutual, meaningful, and affirming moments of connection in the youngest
Chiari type I malformation (CM) and syringomyelia (SM) are closely associated but incompletely understood disorders of the craniovertebral junction and
Chronic pain is common and often undertreated. Access to effective, nonpharmacologic therapies is limited, especially in low-income and ethnically diverse